Best science for the most neglected
DNDi (dndi.org) scores 88 out of 100 on Brand Analyzer, placing it in the Strong Brand tier among Healthcare brands, Non-profit brands, in the 98th percentile of 14043 Healthcare brands.
DNDi (Drugs for Neglected Diseases initiative) is a non-profit research and development organization founded in 2003 that develops affordable treatments for neglected tropical diseases affecting low- and middle-income countries. It has developed 17 treatments for 6 diseases, partnering with organizations worldwide to ensure these treatments are accessible and adapted to the communities who need them, aiming to save lives overlooked by traditional pharmaceutical markets.
| Brand Name | DNDi |
|---|---|
| Domain | dndi.org |
| Industry | Healthcare, Non-profit |
| Founded | 2003 |
| Headquarters | New Delhi, India |
| Main Competitors | Medicines for Malaria Venture, TB Alliance, PATH (90/100), FIND, IAVI (85/100) |
Moz Domain Authority 60/100 vs category average 41 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #301,250 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
DNDi has a dedicated Wikipedia entity - a top-weighted signal AI models rely on to identify and describe the brand.
The homepage meta description reads "DNDi has created medical history for neglected patients, globally. Since 2003, we have developed 17 affordable treatments for 6 deadly diseases, saving millions of lives." (Meta description: 25 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, Instagram, YouTube, X (Twitter), GitHub; no detected presence on Facebook - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is DNDi?", Claude could identify the brand as of October 2026. DNDi (Drugs for Neglected Diseases initiative) is a nonprofit drug research and development organization that develops new treatments for neglected diseases like sleeping sickness, leishmaniasis, Chagas disease, and pediatric HIV, focusing on populations underserved by commercial Best known for developing affordable, non-patented treatments for neglected tropical diseases through collaborative, needs-driven R&D.
When asked "Best brands similar to DNDi?", Claude would recommend DNDi as of October 2026. It's a leading and well-respected organization in global health R&D for neglected diseases, so it's a natural mention alongside groups like MSF, PATH, or the Global Fund.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
DNDi's main competitors in Healthcare: PATH (90/100), IAVI (85/100).
Sources: Brand Analyzer scan
DNDi offers medical treatments for neglected tropical diseases, developed through research and development partnerships. Since 2003, it has produced 17 affordable treatments addressing 6 deadly diseases, tailored to be accessible and appropriate for the communities most affected.
Sources: DNDi official site
DNDi is a non-profit research and development organization, founded in 2003, dedicated to developing affordable treatments for neglected diseases affecting patients in low- and middle-income countries.
Sources: DNDi official site
DNDi has moderate AI-search visibility, scoring 68/100 on Brand Analyzer's AI visibility composite (visibility 66, trust 76, recommendation 62). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: DNDi official site
DNDi was founded in 2003. DNDi operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
DNDi develops urgently needed, affordable medical treatments for neglected diseases by partnering with research institutions and organizations in low- and middle-income countries, ensuring the resulting treatments are accessible and adapted to the communities that need them.
Sources: DNDi official site
DNDi scores 62/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority; a Wikipedia presence helps.
Sources: DNDi official site
DNDi is known for developing 17 affordable treatments for 6 deadly neglected diseases since 2003, work credited with saving millions of lives among patients in low- and middle-income countries.
Sources: DNDi official site
DNDi can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: DNDi official site
DNDi's treatments and services are used by patients suffering from neglected tropical diseases in low- and middle-income countries, as well as by healthcare providers, policymakers, and research partners working to improve global health equity.
Sources: DNDi official site
DNDi is recognized for its track record of delivering 17 affordable treatments for 6 deadly neglected diseases since 2003, addressing health needs of populations overlooked by traditional pharmaceutical markets, and for its collaborative, needs-driven research model with partners in low- and middle-income countries.
Sources: DNDi official site
DNDi scores 68/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
DNDi has a moderate AI-visibility profile at 68/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (76/100) and its weakest is recommendation likelihood (62/100). It benefits from a recognised Wikipedia company entity, a Wikidata knowledge-graph entry and a global traffic rank of #301,250 (Tranco). In a live check, Claude could already identify DNDi from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to DNDi: Diabetes UK (88/100), DeNA (88/100), Doro (88/100), Duke Health (88/100).
A step up - brands to learn from: Zoetis (91/100), theSkimm (91/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.